Research News

Super-small particles of silicon react with water to produce hydrogen almost instantaneously, according to UB researchers.

Customers who connect with a business through social media will go to the business more frequently and contribute more to its bottom line, according to a new study from the School of Management.

Nanoparticles that “teach” the immune system to tolerate protein-based drugs. Vascular grafts that stimulate regeneration of blood vessels in a patient’s body. These innovations may sound like the stuff of the future, but they’re part of a portfolio of inventions that UB announced over the past year.

The debate about gun control in the U.S. is not related to American Revolutionary thought, as gun control opponents often claim, but is grounded in post-Civil War paranoia, according to a UB historian.

Management efforts to reduce cynicism and enhance employee empowerment can have a large impact on employee engagement, according to a School of Management study.

Patients suffering from the painful autoimmune disease Sjogren’s Syndrome soon will be able to be properly diagnosed much earlier, thanks to the discovery of novel antibodies by researchers at UB and Immco Diagnostics Inc. The breakthrough, described in a paper in the December issue of Clinical Immunology,  will allow patients to be treated sooner when they are much more likely to benefit.

Coral colonies that suffered tissue damage in The Bahamas were still producing low numbers of eggs four years after the injuries occurred, according to new research by UB scientists. Tiny sperm-producing factories called spermaries were also in short supply.

To keep Buffalo’s senior citizens healthy and active in the community, they must be able to live comfortably in their own homes.

The Larkin District and its development and planning team, including the School of Architecture and Planning, won an honorable mention at the prestigious National Award for Smart Growth Achievement ceremony held earlier this month in Washington, D.C.

Good news may be on the horizon for Kate Middleton, Duchess of Cambridge, and other women stricken with severe nausea and vomiting during pregnancy, thanks to the work of a UB faculty member who is conducting research on a drug that is showing success treating pregnant women with this condition.